Q3 Earnings Decline Amidst Margin Pressure; Key Litigation Threat Reduced
Summary
Village Super Market reported a nearly 20% drop in Q3 net income and diluted EPS, alongside a slight dip in same-store sales, but a major legal threat from its principal supplier, Wakefern, was procedurally dismissed.
Key Events
-
Q3 Net Income and EPS Decline
Net income for the 13 weeks ended April 25, 2026, decreased by 19.69% to $9.0 million, with Class A diluted EPS falling 18.67% to $0.61, compared to the prior year period.
-
Same-Store Sales Slip
Same-store sales for the quarter decreased by 0.2%, though they would have increased by 1.3% excluding the estimated impact of Winter Storm Fern.
-
Gross Margin Pressure
Gross profit as a percentage of sales decreased by 0.69 percentage points to 28.08% in Q3, primarily due to lower patronage dividends from Wakefern, increased warehouse charges, unfavorable product mix, and higher promotional spending.
-
Key Litigation Threat Removed
Wakefern Food Corp.'s counterclaim, which sought to compel Village Super Market to sell its stock and exit the cooperative, was rejected as procedurally deficient and will not be re-filed. This significantly reduces a major risk highlighted in previous filings.
Analysis
Village Super Market reported a significant decline in Q3 net income and diluted EPS, down nearly 20% year-over-year, driven by lower gross profit margins and increased operating expenses. Same-store sales also saw a slight decline. However, a critical development in the ongoing litigation with its principal supplier, Wakefern Food Corp., provides a positive counterpoint: Wakefern's counterclaim seeking to compel Village Super Market to sell its stock and exit the cooperative was procedurally rejected and will not be included in amended pleadings. This removes an immediate, severe threat to the company's operational structure, balancing the negative financial performance.
At the time of this filing, VLGEA was trading at $39.29 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $522.8M. The 52-week trading range was $30.08 to $48.21. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.